Skip to content

Clinical trials

Observational Carcinoma, Non-Small-Cell Lung trials in the Netherlands

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Non-Small-Cell Lung Phase: Observational Country / region: Netherlands Clear all

30 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20062
20101
20133
20144
20152
20164
20173
20184
20192
20211
20221
20231
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed16
Unknown status5
Recruiting3
Active, not recruiting2
Terminated2
Withdrawn2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Maastricht Radiation Oncology11
University Medical Center Groningen4
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)3
AstraZeneca2
Boehringer Ingelheim1
Dutch Society of Physicians for Pulmonology and Tuberculosis1
Erasmus Medical Center1
European Organisation for Research and Treatment of Cancer - EORTC1
Hoffmann-La Roche1
Leiden University Medical Center1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Non-Small-Cell Lung30
Melanoma3
Lung Neoplasms2
Pancreatic Neoplasms2
Small Cell Lung Carcinoma2
Adenocarcinoma1
Breast Neoplasms1
Breast Neoplasms, Male1
Cachexia1
Carcinoma, Hepatocellular1

Trials

Showing 1 to 25 of 30. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.